2021 Global ANGPTL3 ASPIRE* Cardiovascular Competitive Grant Program

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

The intent of this Request for Proposal (RFP) is to support basic science, pre-clinical research and clinical research through a competitive grants program that advances medical knowledge of the role of ANGPTL3 in health and disease.

The following types of research projects are considered in scope and will be eligible for this program:

o Basic science, pre-clinical research and clinical research that aligns with the in-scope research topics (i.e., animal models, in vivo/in vitro studies)

o Animal experimentation related to human biology

o Translational studies

LOI due date: March 12, 2021

Agency Website

Eligibility Requirements

Geographic Scope • Global

To be eligible: • Only organizations are eligible to receive grants, not individuals or medical practice groups. • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. • Applicant must be affiliated with a host institution. • Both early career and experienced investigators are encouraged to apply and consideration will be given to all proposals meeting the selection criteria.



Amount Description

Individual projects requesting up to USD $250,000 will be considered. Pfizer anticipates a total fund of USD $750,000. Research is expected to be completed and submitted for presentation/publication within 3 years of study start. Smaller, high-quality, innovative grant requests with anticipated results within 12-18 months will be enthusiastically considered.

Funding Type



Junior Faculty


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

March 12, 2021